DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant  ☑                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to § 240.14a-12
BAUSCH HEALTH COMPANIES INC.
(Name of Registrant as Specified In Its Charter)
        
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

    

   

 

  (2)  

Aggregate number of securities to which transaction applies:

 

    

   

 

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

 

    

   

 

  (4)  

Proposed maximum aggregate value of transaction:

 

    

   

 

  (5)   Total fee paid:
        
   

 

  Fee paid previously with preliminary materials.
 

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

  (1)  

Amount Previously Paid:

 

    

   

 

  (2)  

Form, Schedule or Registration Statement No.:

 

    

   

 

  (3)  

Filing Party:

 

    

   

 

  (4)  

Date Filed:

 

    

   

 

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on April 30, 2019.

 

BAUSCH HEALTH COMPANIES INC.

 

 

LOGO

BAUSCH HEALTH COMPANIES INC.

ATTN: CHRISTINA M. ACKERMANN

2150 SAINT ELZEAR BLVD. WEST

LAVAL, QUEBEC H7L 4A8

CANADA

 

LOGO

 

Meeting Information

 

Meeting Type:          Annual Meeting

 

For holders as of:   March 4, 2019

 

Date:    April 30, 2019      Time:   9:00 a.m. (local time)

 

Location:

 

 

2150 Saint Elzear Blvd.West

    Laval, Quebec H7L 4A8 Canada
     

 

You are receiving this communication because you hold shares in the company named above.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

 


— Before You Vote —

How to Access the Proxy Materials

 

 

 

Proxy Materials Available to VIEW or RECEIVE:

Notice of Annual Meeting of Shareholders and Management Proxy Circular and Proxy Statement

Annual Report

 

How to View Online:

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

1)  BY INTERNET:

   www.proxyvote.com
 

2)  BY TELEPHONE:

   1-800-579-1639
 

3)  BY E-MAIL*:

   sendmaterial@proxyvote.com
 

 

*     If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 16, 2019 to facilitate timely delivery.

 

 

— How To Vote —

Please Choose One of the Following Voting Methods

 

LOGO     

 

 

 

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 


Voting Items  

The Board of Directors recommends you vote FOR proposals 1, 2 and 3.

 

1.

Election of Directors

 

  1a.

Richard U. De Schutter

 

  1b.

D. Robert Hale

 

  1c.

Dr. Argeris (Jerry) N. Karabelas

 

  1d.

Sarah B. Kavanagh

 

  1e.

Joseph C. Papa

 

  1f.

John A. Paulson

 

  1g.

Robert N. Power

 

  1h.

Russel C. Robertson

 

  1i.

Thomas W. Ross, Sr.

 

  1j.

Andrew C. von Eschenbach, M.D.

 

  1k.

Amy B. Wechsler, M.D.

 

 

LOGO

 

 

2.

 

The approval, in an advisory vote, of the compensation of our Named Executive Officers.

 

3.    

 

To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2020 Annual Meeting of Shareholders and to authorize the Company’s Board of Directors to fix the auditors’ remuneration.

 

Without limiting the general powers hereby conferred, the undersigned hereby directs the proxyholder to vote the Common Shares represented by this proxy in the manner set forth above.

 

 


 

 

 

 

 

 

LOGO